Therapeutic Efficacy of Plasmalogens for Alzheimer’s Disease, Mild Cognitive Impairment, and Parkinson’s Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer’s Disease
Fujino T, Hossain MS, Mawatari S.
Adv Exp Med Biol. 2020;1299:195-212. doi: 10.1007/978-3-030-60204-8_14.
ニュース
2020.02.10